AKT1 and hepatocellular carcinoma: Upregulated miR-29-3p could inhibit hepatocellular carcinoma cell proliferation, migration, invasion, and metastasis through inhibition of Robo1 and inactivation of the PI3K/Akt/mTOR signaling pathway [27].